UPS Names Angela Hwang To Board Of Directors
13 Juillet 2020 - 3:00PM
UPS (NYSE:UPS) today announced that its board of directors has
appointed Angela Hwang to the board, effective immediately.
Hwang, age 54, is a member of Pfizer’s Executive Team and is
Group President of the Pfizer Biopharmaceuticals Group, which
comprises approximately 80% of Pfizer’s revenues. In this role, she
leads more than 26,000 global colleagues and has responsibility for
bringing over 600 innovative medicines and products to patients
around the world.
“The UPS Board engaged in a thorough search and evaluation to
find the right candidate for this role,” said UPS Executive
Chairman of the Board David Abney. “Angela’s expertise in the
healthcare sector will bring added talent to our Board as we
oversee the company’s strategic growth efforts in this area.”
Hwang oversees seven commercial business units, which in 2019
generated nearly $40 billion in revenues, and impacted the lives of
over 434 million patients across 125 countries. Together, these
businesses strive to deliver transformational medicines that
address major global health priorities in cancer, rare disease,
inflammation & immunology, primary care, infectious diseases,
and preventative care with vaccines.
“Angela is an outstanding, proven leader who brings added
healthcare and global management experience to our Board,” said UPS
Chief Executive Officer Carol Tomé. “We couldn’t be more thrilled
to welcome Angela to the UPS Board of Directors during this time
when UPS continues to expand its leadership in the healthcare
logistics space, launching new healthcare services for UPS
customers.”
Hwang is a 23-year veteran of Pfizer, and has held numerous
leadership roles within the company. Prior to leading the Pfizer
Biopharmaceuticals Group, she held more than 10 different positions
in the company, spanning strategy, product development, marketing,
sales, and general management. She is known as a transformational
leader who drives for innovation and outstanding business
performance and her experience covers a wide array of therapeutic
areas and medicines in all lifecycle stages, as well as
geographical breadth in both developed and emerging markets.
Hwang also sits on the boards of EFPIA (European Federation of
Pharmaceutical Industries and Associations), as well as the Pfizer
Foundation, a charitable organization that addresses global health
challenges. She has been active in industry groups such as BIO (the
Biotechnology Innovation Organization), where she previously
co-chaired the Vaccines Policy Committee. In 2019, she was named to
Crain’s Notable Women in Healthcare list.
Her appointment brings the total number of directors to 13. She
is joining the Board’s Audit Committee.
Hwang received a Bachelor of Science in Microbiology and
Biochemistry from the University of Cape Town, and an MBA from
Cornell University.
About UPS
UPS (NYSE: UPS) is a global leader in logistics, offering a
broad range of solutions including transporting packages and
freight; facilitating international trade, and deploying advanced
technology to more efficiently manage the world of business.
Headquartered in Atlanta, UPS serves more than 220 countries and
territories worldwide. UPS was awarded America’s Best Customer
Service company for Shipping and Delivery services by Newsweek
magazine; Forbes Most Valuable Brand in Transportation; and top
rankings on the JUST 100 list for social responsibility, the Dow
Jones Sustainability World Index, and the Harris Poll Reputation
Quotient, among other prestigious rankings and awards. The company
can be found on the web at ups.com or pressroom.ups.com and its
corporate blog can be found at ups.com/longitudes The company’s
sustainability eNewsletter, UPS Horizons, can be found
at ups.com/sustainabilitynewsletter. To get UPS news direct,
follow @UPS_News on Twitter. To ship with UPS, visit
ups.com/ship.
UPS Media Relations
404-828-7123
pr@ups.com
United Parcel Service (NYSE:UPS)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
United Parcel Service (NYSE:UPS)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024